Bridgeway Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$165K	Sell	25,700 -130,000	-83%	-$833K	﹤0.01%	998
2025 Q1	$551K	Buy	155,700 +9,200	+6%	+$32.6K	0.01%	730
2024 Q4	$554K	Buy	146,500 +16,500	+13%	+$62.4K	0.01%	791
2024 Q3	$421K	Hold	130,000	–	–	0.01%	901
2024 Q2	$247K	Buy	+130,000	New	+$247K	0.01%	1009